Skip to main content

Table 1 List of antidepressants utilized in this study

From: Pre-clinical evaluation of CYP 2D6 dependent drug–drug interactions between primaquine and SSRI/SNRI antidepressants

Antidepressant

Enzymes involved in biotransformation

Enzymes inhibited by antidepressant

Citalopram

CYP2C19, CYP2D6, and CYP3A4

CYP2D6 (weak)

Escitalopram

CYP2C19, CYP2D6, and CYP3A4

CYP2D6 (weak)

Fluoxetine

CYP2D6, CYP2C9, CYP2C19, and CYP3A4

CYP2D6 (strong), CYP2C9 (moderate), CYP2C19, (weak to moderate), CYP3A4 (weak to moderate), CYP1A2 (weak)

Fluvoxamine

CYP1A2 and CYP2D6

CYP2D6 (weak), CYP1A2 (strong), CYP2C19 (strong), CYP2C9 (moderate), CYP3A4 (moderate)

Paroxetine

CYP2D6 and CYP3A4

CYP2D6 (strong), CYP1A2 (weak), CYP2C9 (weak), CYP2C19 (weak), CYP3A4 (weak)

Sertraline

CYP2C9, CYP2C19, CYP2D6, and CYP3A4

CYP2D6 (weak to moderate), CYP1A2 (weak), CYP2C9 (weak), CYP2C19 (weak), CYP3A4 (weak)

Venlafaxine

CYP2D6 and CYP3A4

CYP2D6 (weak)

Desvenlafaxine

CYP3A4

CYP3A4 (weak)

  1. Shown are the enzymes responsible for metabolism of each antidepressant, and enzymes each that each molecule inhibits. Table was adapted from [22]